Lotus Resources has halted production at its Kayelekera uranium mine due to acid supply interruptions linked to Middle East geopolitics and acid plant issues, while advancing export permits and pursuing new funding arrangements.
- Production paused over acid supply and plant repairs
- May output surged to 73.6k lbs U3O8 before halt
- Export permits progressing but delays impact offtake
- Non-binding US$30 million facility with Mercuria underway
- Cash balance of US$26 million; funding options ongoing
Production Halted as Acid Supply Disrupted by Geopolitical Tensions
Lotus Resources (ASX:LOT) has temporarily suspended operations at its Kayelekera uranium mine in Malawi after disruptions to its third-party sulphuric acid supply chain, a fallout of ongoing Middle East geopolitical tensions. The company’s own acid plant commissioning has also hit a snag, with refractory brick failures in the sulphur furnace necessitating repairs. These issues have forced Lotus to pause production despite recent operational gains.
Before the disruption, Kayelekera was on an upward trajectory, with May 2026 production hitting 73,600 pounds of U3O8, a significant jump from 47,300 pounds in April and approaching the quarterly total of 78,300 pounds. This improvement reflected targeted optimisation and equipment upgrades. However, steady-state production is now deferred to later in 2026, contingent on acid supply stabilisation and plant repairs.
Export Permitting Progressing but Delays Threaten Offtake Commitments
Lotus is advancing the regulatory approvals needed to ship uranium concentrate from Malawi through Zambia and Namibia to France, where Orano CE will process the material. The company has secured key permits from Malawian and Zambian authorities and is finalising contracts for shipping from Walvis Bay port.
However, delays in export permitting and production interruptions are jeopardising Lotus’ ability to meet its 2026 offtake obligations of 1.01 million pounds of U3O8. The company is negotiating with customers to defer a significant portion of deliveries into 2027. Financially, Lotus’ maximum liability for undelivered uranium in 2026 is capped at approximately US$10 million, based on current spot prices, with undelivered product retained for future sale.
Mercuria Marketing Agreement and Inventory Prepayment Facility in the Works
In a bid to shore up working capital, Lotus has executed a non-binding term sheet with Mercuria Energy Trading S.A. for a marketing agreement covering 3 million pounds of uranium over 30 months at spot-related pricing. Crucially, this includes a prepayment facility of up to US$30 million, accessible from the anticipated first shipment in September 2026. The facility’s cost will be tied to the Secured Overnight Financing Rate plus a margin.
This arrangement follows extensive due diligence, including site visits and an independent technical review, and is expected to be formalised within the next two months. It represents a significant step in addressing the company’s near-term funding needs.
Funding Needs and Voluntary Suspension Extension
Lotus currently holds US$26 million in cash but acknowledges that external funding is essential to maintain operations and complete commissioning. The company is actively pursuing equity and quasi-equity options, with progress dependent on demonstrating sustainable production and resolving offtake commitments.
Given these uncertainties, Lotus has requested an extension of its voluntary suspension from ASX trading until either funding is secured or normal trading resumes on 16 July 2026. The company warns that trading before funding finalisation could mislead the market and jeopardise its financial viability.
Operational Challenges Seen as Transitional with Upside Potential
Despite the current setbacks, Lotus maintains that the Kayelekera mine is approaching a critical inflection point. Operational improvements prior to the pause suggest the asset is moving toward steady-state production and sustainable cash flow generation. The company’s strategy hinges on overcoming acid supply constraints and export permitting hurdles, while leveraging the Mercuria facility and other funding initiatives to stabilise operations.
This update underscores the delicate balance Lotus faces between operational execution and financial strategy amid external geopolitical pressures and complex logistics. The path to full production ramp-up remains contingent on resolving these intertwined challenges.
Bottom Line?
Lotus’ near-term viability hinges on resolving acid supply issues and securing funding, with steady-state production now pushed to later in 2026.
Questions in the middle?
- Will Lotus secure binding funding agreements before the ASX suspension lifts?
- How will ongoing Middle East tensions continue to affect acid supply and costs?
- Can export permitting delays be shortened to avoid further offtake penalties?